Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platinum(II) binding to metallothioneins.

J Bongers1, J U Bell, D E Richardson

  • 1Department of Chemistry, University of Florida, Gainesville 32611.

Journal of Inorganic Biochemistry
|September 1, 1988
PubMed
Summary

Equine metallothionein reacts with platinum compounds to form adducts. These findings offer insights into platinum anticancer drug metabolism and metallothionein interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Dutch Dystrophinopathy Database: A National Registry with Standardized Patient and Clinician Reported Real-World Data.

Journal of neuromuscular diseases·2024
Same author

Suspected tick-borne flavivirus meningoencephalomyelitis in dogs from the UK: six cases (2021).

The Journal of small animal practice·2023
Same author

Three rs approaches in the production and quality control of avian vaccines.

Alternatives to laboratory animals : ATLA·2014
Same author

The mass-to-charge ratio scale.

Journal of the American Society for Mass Spectrometry·2013
Same author

Mechanism of sulfide oxidations by peroxymonocarbonate.

Inorganic chemistry·2001
Same author

Frontal sinus osteoma associated with cerebral abscess formation: a case report.

Surgical neurology·2001

Area of Science:

  • Biochemistry
  • Metalloprotein Chemistry

Background:

  • Metallothioneins (MT) are cysteine-rich proteins involved in metal detoxification.
  • Platinum compounds are crucial in cancer chemotherapy.

Purpose of the Study:

  • To investigate the reaction of equine renal metallothionein (MT) with potassium tetrachloroplatinate (K2PtCl4).
  • To characterize the resulting platinum-MT adducts and propose a structural model.
  • To discuss the implications for platinum-based anticancer drug metabolism.

Main Methods:

  • Reaction of equine MT with K2PtCl4 at different pH values.
  • Characterization of platinum adducts using chemical modification assays (DTNB, iodoacetic acid).
  • Structural modeling of the platinum-MT adduct.

Main Results:

  • Polymeric and monomeric platinum-MT adducts were formed, with varying platinum stoichiometry (17±2 mol Pt/mol MT at pH 2, 7 mol Pt/mol MT at neutral pH).
  • Coordination of Pt2+ to cysteine thiolate residues was confirmed, with 11±2 mol cys/mol MT reacting.
  • A structural model of Pt7MT was proposed, featuring a three-metal beta cluster incorporating a tetrathiolate Pt(II) unit.

Conclusions:

  • The study elucidates the complexation of platinum with metallothionein.
  • The findings provide a structural basis for understanding platinum binding to MT.
  • This research has implications for the pharmacokinetics and efficacy of platinum anticancer drugs.

Related Experiment Videos